Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center

• Status: Completed
• Trial end date: 2020-01-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if a single dose of sublingual sufentanil is as or more efficacious than a single dose of IV fentanyl in a post anesthesia care setting.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Minnesota
• Treatments: Fentanyl; Sufentanil

Criteria

Inclusion Criteria:

• undergoing outpatient ambulatory surgery

• recipient of general anesthesia

• pain score of 4 or greater in the PACU

Exclusion Criteria:

• non-english speaking patients

• cancer surgeries

• patients who have allergy or intolerance to the study drugs or derivatives

• patients on chronic opioids (defined as daily opioids for 3 months or longer)